Analysis of Accendra Health Inc (ACH)’s performance, earnings and valuation

Nora Barnes

Accendra Health Inc [ACH] stock prices are down -6.34% to $2.51 at the moment. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The ACH shares have gain 31.41% over the last week, with a monthly amount drifted -14.92%, and not seem to be holding up well over a long-time horizon.

From an analyst’s perspective:

Accendra Health Inc [NYSE: ACH] stock has seen the most recent analyst activity on November 03, 2025, when UBS downgraded its rating to a Neutral but kept the price target unchanged to $4 for it. Previously, Citigroup upgraded its rating to Buy on July 19, 2024, and dropped its price target to $19. On February 26, 2024, Leerink Partners initiated with a Market Perform rating and assigned a price target of $24 on the stock. Barclays started tracking the stock assigning a Equal Weight rating and suggested a price target of $21 on January 03, 2024. Citigroup downgraded its rating to a Neutral and reduced its price target to $18 on October 13, 2022. Robert W. Baird downgraded its rating to Neutral for this stock on October 12, 2022, and downed its price target to $22. In a note dated October 12, 2022, BofA Securities downgraded an Underperform rating on this stock and revised its target price from $43 to $17.

The stock price of Accendra Health Inc [ACH] has been fluctuating between $1.84 and $15.54 over the past year. Currently, Wall Street analysts expect the stock to reach $6.33 within the next 12 months. Accendra Health Inc [NYSE: ACH] shares were valued at $2.51 at the most recent close of the market. An investor can expect a potential return of 152.19% based on the average ACH price forecast.

Analyzing the ACH fundamentals

The Accendra Health Inc [NYSE:ACH] reported sales of 6.71B for trailing twelve months, representing a drop of -74.38%. Gross Profit Margin for this corporation currently stands at 0.26% with Operating Profit Margin at -0.04%, Pretax Profit Margin comes in at -0.06%, and Net Profit Margin reading is -0.2%. To continue investigating profitability, this company’s Return on Assets is posted at -0.33, Equity is -12.6 and Total Capital is -0.18. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of-5.11.

Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.

Ratios To Look Out For

It’s worth pointing out that Accendra Health Inc [NYSE:ACH]’s Current Ratio is 0.86. Further, the Quick Ratio stands at 0.84, while the Cash Ratio is 0.01. Considering the valuation of this stock, the price to sales ratio is 0.03.

Transactions by insiders

Recent insider trading involved Coliseum Capital Management, L, 10% Owner, that happened on Aug 12 ’25 when 0.72 million shares were purchased. 10% Owner, Coliseum Capital Management, L completed a deal on Aug 14 ’25 to buy 0.49 million shares. Meanwhile, 10% Owner Coliseum Capital Management, L bought 0.33 million shares on Aug 13 ’25.

MZP News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.